CPI Card Group (PMTS) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Net sales rose 9% year-over-year to $129.8M in Q2 2025, or 15% excluding a one-time accounting change, driven by Arroweye acquisition and debit/credit card growth.
Arroweye contributed nearly $10M in net sales in less than two months and outperformed profitability expectations.
Card@Once instant issuance solution grew over 20% in the first half, expanding to 17,000+ locations and entering the government disbursement vertical.
Margin pressures arose from sales mix, higher production costs, and tariffs.
Strategic investments in automation, new facilities, and market expansion are expected to drive long-term growth.
Financial highlights
Q2 2025 net sales: $129.8M (up 9% year-over-year; up 15% excluding accounting change); six months: $252.5M (up 9%).
Q2 2025 net income: $0.5M (down 91% year-over-year); six months: $5.3M (down 54%).
Adjusted EBITDA grew 3% to $22.5M; margin declined to 17.3% from 18.4%.
Gross margin fell to 30.9% from 35.7% year-over-year, pressured by sales mix, higher tariffs, and costs from the Indiana facility transition.
Free cash flow for H1 2025 was $0.8M, down from $1.4M, due to higher capital expenditures.
Outlook and guidance
2025 net sales outlook raised to low double-digit to mid-teens growth, reflecting Arroweye addition; prior outlook was mid- to high single-digit growth.
Adjusted EBITDA outlook unchanged at mid- to high single-digit growth, as Arroweye benefits are offset by tariffs and sales mix.
Guidance does not include potential impacts from proposed chip tariffs announced August 6, 2025.
Margin pressures expected to persist in Q3, with improvement anticipated in Q4 as the Indiana facility ramps up.
Long-term growth trends remain positive, supported by recurring business and adoption of higher-value cards.
Latest events from CPI Card Group
- Record Q4 revenue and robust 2025 growth set stage for continued expansion in 2026.PMTS
Q4 20255 Mar 2026 - Q2 net sales up 3–3.4%, profits down on higher SG&A, outlook raised, debt refinanced.PMTS
Q2 20244 Feb 2026 - Q4 net sales up 22% and net income up 148%; 2025 outlook projects further growth.PMTS
Q4 20244 Feb 2026 - Q1 2025 net sales up 10%, net income down 12%, Arroweye expands digital card solutions.PMTS
Q1 20254 Feb 2026 - Q3 2025 net sales up 11%, net income up 78%, but margins and 2025 outlook declined.PMTS
Q3 20254 Feb 2026 - Q3 net sales up 18% and outlook raised, but net income down 66% on refinancing costs.PMTS
Q3 202416 Jan 2026 - Board recommends electing eight directors, auditor ratification, and approving executive pay.PMTS
Proxy Filing2 Dec 2025 - Annual meeting to elect directors, ratify auditor, and vote on executive pay, all board-backed.PMTS
Proxy Filing2 Dec 2025